Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bleyer

Showing results (231-240 of 664) with videos related to

Pageof 67
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 1, 1996
Utilization of inpatient and outpatient resources for the management of hemodialysis access complicationsM V Rocco, A J Bleyer, J M Burkart
Advances in Chronic Kidney Disease|March 13, 2017
Autosomal Dominant Tubulointerstitial Kidney DiseaseAnthony J Bleyer, Kendrah Kidd, Martina Živná, et al.
Blood|May 1, 1978
"Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasmsW A Bleyer, D G Poplack, R M Simon
The New England Journal of Medicine|October 11, 1973
Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemiaW A Bleyer, J C Drake, B A Chabner
Clinical Journal of the American Society of Nephrology : CJASN|May 15, 2012
Nephrology quiz and questionnaire: renal replacement therapyThomas A Golper, , Richard J Glassock, et al.
Neurology|January 1, 1976
Spinal descent of cerebrospinal fluid in manG D Chiro, M K Hammock, W A Bleyer
Journal of Pediatric Hematology/Oncology|January 4, 1998
Accumulation of methotrexate in systemic tissues after intrathecal administrationW A Bleyer, J A Nelson, B A Kamen
Cancer Medicine|September 30, 2021
Patterns of National Cancer Institute-Sponsored Clinical Trial Enrollment in Black Adolescents and Young AdultsMichael Roth, Melissa Beauchemin, Justine M Kahn, et al.
Cancer Treatment Reports|June 1, 1979
Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study GroupW A Bleyer, W Krivit, R L Chard, et al.
Die Pharmazie|September 1, 1991
Sublytic doses of streptolysin O-effects on the metabolic fate of procainamide in ratsW Siegmund, E Hadasova, G Franke, et al.
Pageof 67

Showing results (231-240 of 664) with videos related to

Sort By:
Pageof 67
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 1, 1996
Utilization of inpatient and outpatient resources for the management of hemodialysis access complicationsM V Rocco, A J Bleyer, J M Burkart
Advances in Chronic Kidney Disease|March 13, 2017
Autosomal Dominant Tubulointerstitial Kidney DiseaseAnthony J Bleyer, Kendrah Kidd, Martina Živná, et al.
Blood|May 1, 1978
"Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasmsW A Bleyer, D G Poplack, R M Simon
The New England Journal of Medicine|October 11, 1973
Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemiaW A Bleyer, J C Drake, B A Chabner
Clinical Journal of the American Society of Nephrology : CJASN|May 15, 2012
Nephrology quiz and questionnaire: renal replacement therapyThomas A Golper, , Richard J Glassock, et al.
Neurology|January 1, 1976
Spinal descent of cerebrospinal fluid in manG D Chiro, M K Hammock, W A Bleyer
Journal of Pediatric Hematology/Oncology|January 4, 1998
Accumulation of methotrexate in systemic tissues after intrathecal administrationW A Bleyer, J A Nelson, B A Kamen
Cancer Medicine|September 30, 2021
Patterns of National Cancer Institute-Sponsored Clinical Trial Enrollment in Black Adolescents and Young AdultsMichael Roth, Melissa Beauchemin, Justine M Kahn, et al.
Cancer Treatment Reports|June 1, 1979
Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study GroupW A Bleyer, W Krivit, R L Chard, et al.
Die Pharmazie|September 1, 1991
Sublytic doses of streptolysin O-effects on the metabolic fate of procainamide in ratsW Siegmund, E Hadasova, G Franke, et al.
Pageof 67